Diplomat Pharmacy, Inc.·4

Feb 10, 4:15 PM ET

DREYER DAVID C 4

4 · Diplomat Pharmacy, Inc. · Filed Feb 10, 2020

Insider Transaction Report

Form 4
Period: 2020-02-10
Transactions
  • Disposition from Tender

    Common Stock

    2020-02-10$4.00/sh19,453$77,81220,674 total
  • Disposition to Issuer

    Common Stock

    2020-02-10$4.00/sh20,674$82,6960 total
Footnotes (2)
  • [F1]Represents shares tendered to the Denali Merger Sub, Inc. ("Purchaser") in connection with the closing on February 10, 2020 of a cash tender offer by Purchaser to acquire common stock of Issuer in exchange for $4.00 per share in cash, subject to any required withholding of taxes, without interest.
  • [F2]Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the "Merger Agreement"), by and among UnitedHealth Group Incorporated, a Delaware corporation ("Parent"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the "Issuer"), each outstanding restricted stock award held by reporting person was disposed of pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer.

Documents

1 file
  • 4
    a4.xmlPrimary

    4